Acro Biomedical (ACBM) Net Cash Flow Growth (5y) (2020 - 2025)
Acro Biomedical (ACBM) Net Cash Flow Growth (5y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - |
| 2 | Berto Acquisition | 312.16 Mn | 312.16 Mn | - |
| 3 | Centurion Acquisition | 311.79 Mn | 311.79 Mn | - |
| 4 | Churchill Capital Corp IX | 309.64 Mn | 309.64 Mn | - |
| 5 | WEN Acquisition | 308.55 Mn | 308.55 Mn | - |
| 6 | Agriculture & Natural Solutions Acquisition | 304.08 Mn | 304.08 Mn | - |
| 7 | Bold Eagle Acquisition | 274.25 Mn | 274.25 Mn | - |
| 8 | Soulpower Acquisition | 265.17 Mn | 265.17 Mn | - |
| 9 | BTC Development | 263.21 Mn | 263.21 Mn | - |
| 10 | Acro Biomedical | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 84.01% |
| Jun 30, 2025 | 53.41% |
| Mar 31, 2025 | -15.13% |
| Dec 31, 2024 | 16.70% |
| Sep 30, 2024 | 63.79% |
| Jun 30, 2024 | 15.11% |
| Mar 31, 2024 | 64.00% |
| Dec 31, 2023 | -15.77% |
| Sep 30, 2023 | 16.76% |
| Jun 30, 2023 | 14.93% |
| Mar 31, 2023 | -15.01% |
| Dec 31, 2022 | 18.23% |
| Sep 30, 2022 | -35.59% |
| Mar 31, 2022 | 61.26% |
| Dec 31, 2021 | -234.44% |
| Sep 30, 2021 | -44.64% |
| Jun 30, 2021 | 104.91% |
| Mar 31, 2021 | 22.55% |
| Sep 30, 2020 | 31.74% |